Effect of pentaerythritol tetranitrate (PETN) on the development of fetal growth restriction in pregnancies with impaired uteroplacental perfusion at midgestation-a randomized trial.
Groten T, Lehmann T, Städtler M, Komar M, Winkler JL, Condic M, Strizek B, Seeger S, Jäger Y, Pecks U, Eckmann-Scholz C, Kagan KO, Hoopmann M, von Kaisenberg CS, Brodowski L, Tauscher A, Schrey-Petersen S, Friebe-Hoffmann U, Lato K, Hübener C, Delius M, Verlohren S, Sroka D, Schlembach D, de Vries L, Kraft K, Seliger G, Schleußner E; PETN Study Group.
Groten T, et al. Among authors: stadtler m.
Am J Obstet Gynecol. 2023 Jan;228(1):84.e1-84.e12. doi: 10.1016/j.ajog.2022.07.028. Epub 2022 Aug 2.
Am J Obstet Gynecol. 2023.
PMID: 35931132
Free article.
Clinical Trial.